Rachel Neale from the QIMR Berghofer Medical Research Institute[/caption]
PSA National President Associate Professor Fei Sim FPS[/caption]
Source – Pregabalin prescribing patterns in Australian general practice, 2012–2018: a cross-sectional study[/caption]
National Medicines Symposium 2024 speakers (L to R): Steve Waller, Professor Jennifer Martin, Professor Libby Roughead, Tegan Taylor[/caption]
Pharmacists have another smoking cessation option up their coat sleeve by combining these established medicines.
When pharmacists should and shouldn't prescribe famciclovir as a Schedule 3 antiviral treatment for cold sores.
New guidelines sideline surgery, injectable medicines and opioids for primary healthcare management of knee osteoarthritis.
A paediatric oncologist explains how pharmacists can spot the early warning signs of childhood brain cancer and save lives.
The latest injectable glucagon-like peptide-1 receptor agonist, Wegovy, became available in Australia last week (5 August 2024).
The TGA has issued a warning after receiving reports possibly associating azithromycin with cardiovascular death in several patients.
A record number of attendees flocked to PSA24 to partake in cutting edge education sessions, networking events and a world-class exhibition.
This individualised approach to tapering off psychiatric medicines can help patients withdraw for good, said Dr Mark Horowitz at PSA24.
From the ECP party to the morning walks and member breakfast, pharmacists have had a vast array of social events to choose from at PSA24.
Professor Lisa Nissen revealed where she would like to see pharmacists scope of practice venture, among other experts on a panel at PSA24.
